![William Clementi](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
William Clementi
Corporate Officer/Principal presso
Tiziana Life Sciences Ltd. (United Kingdom)
Profilo
William A. Clementi is currently Chief Development Officer at Tiziana Life Sciences Ltd. (United Kingdom).
Formerly, Dr. Clementi was Chief Operating Officer at OKYO Pharma Ltd. from 2023 to 2024.
Dr. Clementi also served as Worldwide Director-Market Development at Synthélabo SA and Lorex Pharmaceuticals.
Education includes undergraduate studies at Boston University, The University of Texas School of Law, and College of Pharmacy.
Posizioni attive di William Clementi
| Società | Posizione | Inizio |
|---|---|---|
Tiziana Life Sciences Ltd. (United Kingdom)
 Tiziana Life Sciences Ltd. (United Kingdom) BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops transformative therapies for neurodegenerative and neuroinflammatory | Corporate Officer/Principal | - |
Precedenti posizioni note di William Clementi
| Società | Posizione | Fine |
|---|---|---|
| TIZIANA LIFE SCIENCES LTD | Corporate Officer/Principal | 01/08/2025 |
| WEST AFRICAN MINERALS CORP | Direttore operativo | 01/04/2024 |
Lorex Pharmaceuticals
 Lorex Pharmaceuticals Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | - |
Synthélabo SA
 Synthélabo SA Pharmaceuticals: OtherHealth Technology Manufactures pharmaceuticals | Corporate Officer/Principal | - |
Formazione di William Clementi
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
7
Relazioni di 1° grado
8
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 8 |
|---|---|
Synthélabo SA
Synthélabo SA Pharmaceuticals: OtherHealth Technology Manufactures pharmaceuticals | Health Technology |
OKYO Pharma Ltd.
 OKYO Pharma Ltd. BiotechnologyHealth Technology Develops next-generation therapeutics to improve the lives of patients suffering from inflammatory eye diseases | Health Technology |
Boston University
 Boston University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lorex Pharmaceuticals
Lorex Pharmaceuticals Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
The University of Texas School of Law
 The University of Texas School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tiziana Life Sciences Ltd. (United Kingdom)
Tiziana Life Sciences Ltd. (United Kingdom) BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops transformative therapies for neurodegenerative and neuroinflammatory | Health Technology |
College of Pharmacy
 College of Pharmacy Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tiziana Life Sciences Ltd.
 Tiziana Life Sciences Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
